Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1980 |
Neuromedin S(rat)
Neuromedin S (rat) |
||
Potent, endogenous neuromedin U receptor agonist (EC50 values are 65 and 91 pM at NMU1 and NMU2 respectively). Induces phase shifts in the circadian rhythm of locomotor activity following i.c.v. administration. Potent endogenous anorexigenic peptide. | |||
T81683 |
Neuromedin S (human)
|
||
Neuromedin S (human) 是包含33个氨基酸的神经肽,作为G 蛋白偶联受体 (GPCR) FM-4/TGR-1的内源性配体,在大脑中被鉴定,并对神经调节素 U (NMU) 受体 2 (NMUR2)调节体重稳态具有调控作用。 | |||
T81682 |
Neuromedin S(rat) TFA
|
||
Neuromedin S(rat) TFA是一种含有34个氨基酸的肽段,源自大鼠的Neuromedin S,它是一种从大鼠大脑中分离得到的神经肽,能够作为FM4/TGR-1的配体。 | |||
T35597 |
Neuromedin U-23 (rat) (trifluoroacetate salt)
|
||
Neuromedin U-23 (NMU-23) is a neuropeptide involved in diverse biological processes, including smooth muscle contraction, energy homeostasis, and nociception.1It is an agonist of neuromedin-U receptor 1 (NMUR1; EC50= 0.17 nM for the human receptor in a calcium mobilization assay using HEK293 cells) and NMUR2 (EC50= ~1.4-2 nM for arachidonic acid release in CHO cells expressing the human receptor).2,3NMU-23 (1 μM) induces contractions in isolated rat colon smooth muscle strips.4It decreases body ... | |||
T35598 |
Neuromedin U-25 (human) (trifluoroacetate salt)
|
||
Neuromedin U (NMU) is a neuropeptide first demonstrated to drive smooth muscle contraction.1Translated as a 174 amino acid propeptide, NMU is cleaved to different lengths in different animals. It has diverse receptor-mediated rolesin vivo, as it regulates feeding, vasoconstriction, nociception, and bone remodeling and contributes to obesity, cancer and septic shock.2,2NMU-25 is the active form of NMU in humans. It binds with high affinity to receptors on human left ventricle and coronary artery ... |